Karl E Group

Array ( [id] => 1083290 [patent_doc_number] => 06833542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-21 [patent_title] => 'Method for sorting particles' [patent_app_type] => B2 [patent_app_number] => 09/993376 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 47 [patent_no_of_words] => 20951 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833542.pdf [firstpage_image] =>[orig_patent_app_number] => 09993376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1179888 [patent_doc_number] => 06744038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-01 [patent_title] => 'Methods of separating particles using an optical gradient' [patent_app_type] => B2 [patent_app_number] => 09/993326 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 46 [patent_no_of_words] => 20956 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/744/06744038.pdf [firstpage_image] =>[orig_patent_app_number] => 09993326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1135965 [patent_doc_number] => 06784420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Method of separating particles using an optical gradient' [patent_app_type] => B2 [patent_app_number] => 09/993377 [patent_app_country] => US [patent_app_date] => 2001-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 47 [patent_no_of_words] => 20951 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/784/06784420.pdf [firstpage_image] =>[orig_patent_app_number] => 09993377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5905894 [patent_doc_number] => 20020142369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Refolding method of thrombin' [patent_app_type] => new [patent_app_number] => 10/033737 [patent_app_country] => US [patent_app_date] => 2001-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6932 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142369.pdf [firstpage_image] =>[orig_patent_app_number] => 10033737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561261 [patent_doc_number] => 20020164741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Non-aqueous, liquid, enzyme-containing compositions' [patent_app_type] => new [patent_app_number] => 10/035713 [patent_app_country] => US [patent_app_date] => 2001-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11162 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164741.pdf [firstpage_image] =>[orig_patent_app_number] => 10035713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307454 [patent_doc_number] => 20040141976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Treatment of disease by inducing cell apoptosis' [patent_app_type] => new [patent_app_number] => 10/415325 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23354 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141976.pdf [firstpage_image] =>[orig_patent_app_number] => 10415325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1310035 [patent_doc_number] => 06613566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Platelet suspensions and methods for resuspending platelets' [patent_app_type] => B2 [patent_app_number] => 10/029785 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4007 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613566.pdf [firstpage_image] =>[orig_patent_app_number] => 10029785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276662 [patent_doc_number] => 20020106791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Beta taipoxin as a cell growth factor and method' [patent_app_type] => new [patent_app_number] => 10/004085 [patent_app_country] => US [patent_app_date] => 2001-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2324 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106791.pdf [firstpage_image] =>[orig_patent_app_number] => 10004085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241253 [patent_doc_number] => 06683076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-27 [patent_title] => 'Methods for therapeutic use of glucosylceramide synthesis inhibitors and composition thereof' [patent_app_type] => B2 [patent_app_number] => 10/007306 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11610 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683076.pdf [firstpage_image] =>[orig_patent_app_number] => 10007306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253500 [patent_doc_number] => 06670325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-30 [patent_title] => 'Treatment of osteocarcinoma with alpha-1antitrypsin or secretory leucocyte protease inhibitor' [patent_app_type] => B2 [patent_app_number] => 10/034265 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1655 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670325.pdf [firstpage_image] =>[orig_patent_app_number] => 10034265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432805 [patent_doc_number] => 20020127629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Imaging of enzymatic activity' [patent_app_type] => new [patent_app_number] => 09/999665 [patent_app_country] => US [patent_app_date] => 2001-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7414 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127629.pdf [firstpage_image] =>[orig_patent_app_number] => 09999665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6080906 [patent_doc_number] => 20020081732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Electroprocessing in drug delivery and cell encapsulation' [patent_app_type] => new [patent_app_number] => 09/982515 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27638 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081732.pdf [firstpage_image] =>[orig_patent_app_number] => 09982515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128560 [patent_doc_number] => 20020076453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Angiotensin I-converting enzyme inhibitory substance' [patent_app_type] => new [patent_app_number] => 09/978751 [patent_app_country] => US [patent_app_date] => 2001-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3222 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076453.pdf [firstpage_image] =>[orig_patent_app_number] => 09978751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6305919 [patent_doc_number] => 20020094514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Plasma-derived fibrin-based matrices and tissue' [patent_app_type] => new [patent_app_number] => 09/970651 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6199 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094514.pdf [firstpage_image] =>[orig_patent_app_number] => 09970651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1049750 [patent_doc_number] => 06861054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'suPAR stimulating activity of tcuPA-mediated fibrinolysis and different uses thereof' [patent_app_type] => utility [patent_app_number] => 09/968752 [patent_app_country] => US [patent_app_date] => 2001-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4099 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861054.pdf [firstpage_image] =>[orig_patent_app_number] => 09968752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1095651 [patent_doc_number] => 06821746 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Methods of screening for FabK antagonists and agonists' [patent_app_type] => B2 [patent_app_number] => 09/968129 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8905 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821746.pdf [firstpage_image] =>[orig_patent_app_number] => 09968129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340524 [patent_doc_number] => 06586218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Compositions and methods for increasing the yields of in vitro RNA transcription and other polynucleotide synthetic reactions' [patent_app_type] => B2 [patent_app_number] => 09/966062 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16708 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586218.pdf [firstpage_image] =>[orig_patent_app_number] => 09966062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6290141 [patent_doc_number] => 20020055162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Compositions and methods for increasing the yields of in vitro RNA transcription and other polynucleotide synthetic reactions' [patent_app_type] => new [patent_app_number] => 09/966494 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16909 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055162.pdf [firstpage_image] =>[orig_patent_app_number] => 09966494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1303619 [patent_doc_number] => 06620808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-16 [patent_title] => 'Endocrine modulation with positive modulators of AMPA type glutamate receptors' [patent_app_type] => B2 [patent_app_number] => 09/964288 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6595 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620808.pdf [firstpage_image] =>[orig_patent_app_number] => 09964288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696433 [patent_doc_number] => 20030108627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Cranberry based dietary supplement and dental hygiene product' [patent_app_type] => new [patent_app_number] => 09/962771 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2267 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108627.pdf [firstpage_image] =>[orig_patent_app_number] => 09962771 [rel_patent_id] =>[rel_patent_doc_number] =>)